Thomas E. Callis, Ph.D. - Publications

Affiliations: 
2008 Cell & Developmental Biology University of North Carolina, Chapel Hill, Chapel Hill, NC 
Area:
Molecular Biology, Physiology Biology, Genetics

15 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2011 Seok HY, Tatsuguchi M, Callis TE, He A, Pu WT, Wang DZ. miR-155 inhibits expression of the MEF2A protein to repress skeletal muscle differentiation. The Journal of Biological Chemistry. 286: 35339-46. PMID 21868385 DOI: 10.1074/Jbc.M111.273276  0.782
2010 Townley-Tilson WH, Callis TE, Wang D. MicroRNAs 1, 133, and 206: critical factors of skeletal and cardiac muscle development, function, and disease. The International Journal of Biochemistry & Cell Biology. 42: 1252-5. PMID 20619221 DOI: 10.1016/J.Biocel.2009.03.002  0.783
2010 Mandel EM, Kaltenbrun E, Callis TE, Zeng XX, Marques SR, Yelon D, Wang DZ, Conlon FL. The BMP pathway acts to directly regulate Tbx20 in the developing heart. Development (Cambridge, England). 137: 1919-29. PMID 20460370 DOI: 10.1242/Dev.043588  0.588
2010 Callis TE, Jensen BC, Weck KE, Willis MS. Evolving molecular diagnostics for familial cardiomyopathies: at the heart of it all. Expert Review of Molecular Diagnostics. 10: 329-51. PMID 20370590 DOI: 10.1586/Erm.10.13  0.331
2009 Callis TE, Pandya K, Seok HY, Tang RH, Tatsuguchi M, Huang ZP, Chen JF, Deng Z, Gunn B, Shumate J, Willis MS, Selzman CH, Wang DZ. MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice. The Journal of Clinical Investigation. 119: 2772-86. PMID 19726871 DOI: 10.1172/Jci36154  0.772
2009 Chen JF, Callis TE, Wang DZ. microRNAs and muscle disorders. Journal of Cell Science. 122: 13-20. PMID 19092056 DOI: 10.1242/Jcs.041723  0.784
2008 Callis TE, Wang DZ. Taking microRNAs to heart. Trends in Molecular Medicine. 14: 254-60. PMID 18457996 DOI: 10.1016/J.Molmed.2008.03.006  0.745
2008 Tang RH, Zheng XL, Callis TE, Stansfield WE, He J, Baldwin AS, Wang DZ, Selzman CH. Myocardin inhibits cellular proliferation by inhibiting NF-kappaB(p65)-dependent cell cycle progression. Proceedings of the National Academy of Sciences of the United States of America. 105: 3362-7. PMID 18296632 DOI: 10.1073/Pnas.0705842105  0.555
2008 Chen JF, Murchison EP, Tang R, Callis TE, Tatsuguchi M, Deng Z, Rojas M, Hammond SM, Schneider MD, Selzman CH, Meissner G, Patterson C, Hannon GJ, Wang DZ. Targeted deletion of Dicer in the heart leads to dilated cardiomyopathy and heart failure. Proceedings of the National Academy of Sciences of the United States of America. 105: 2111-6. PMID 18256189 DOI: 10.1073/Pnas.0710228105  0.716
2008 Callis TE, Deng Z, Chen JF, Wang DZ. Muscling through the microRNA world. Experimental Biology and Medicine (Maywood, N.J.). 233: 131-8. PMID 18222968 DOI: 10.3181/0709-Mr-237  0.781
2007 Tatsuguchi M, Seok HY, Callis TE, Thomson JM, Chen JF, Newman M, Rojas M, Hammond SM, Wang DZ. Expression of microRNAs is dynamically regulated during cardiomyocyte hypertrophy Journal of Molecular and Cellular Cardiology. 42: 1137-1141. PMID 17498736 DOI: 10.1016/J.Yjmcc.2007.04.004  0.784
2007 Callis TE, Chen JF, Wang DZ. MicroRNAs in skeletal and cardiac muscle development. Dna and Cell Biology. 26: 219-25. PMID 17465888 DOI: 10.1089/Dna.2006.0556  0.782
2006 Chen JF, Mandel EM, Thomson JM, Wu Q, Callis TE, Hammond SM, Conlon FL, Wang DZ. The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation Nature Genetics. 38: 228-233. PMID 16380711 DOI: 10.1038/Ng1725  0.799
2005 Callis TE, Cao D, Wang DZ. Bone morphogenetic protein signaling modulates myocardin transactivation of cardiac genes. Circulation Research. 97: 992-1000. PMID 16224060 DOI: 10.1161/01.Res.0000190670.92879.7D  0.588
2005 Mandel EM, Callis TE, Wang D, Conlon FL. Transcriptional mechanisms of congenital heart disease Drug Discovery Today: Disease Mechanisms. 2: 33-38. DOI: 10.1016/J.Ddmec.2005.05.034  0.561
Show low-probability matches.